 | • レポートコード：GIR-107A12588 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ポイントオブケア感染症のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ポイントオブケア感染症の種類別市場規模（HIV POC、クロストリジウム・ディフィシルPOC、HBV POC、肺炎・連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TB・薬剤耐性結核POC）、用途別市場規模（病院、クリニック、在宅、生活支援医療施設、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ポイントオブケア感染症の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Siemens Healthineers、Trivitron Healthcare、F. Hoffmann-La Roche Ltd、Abbott、Quest Diagnostics, Inc、BD & Company、Chembio Diagnostics Inc、Trinity Biotech、Cardinal Health、Bio-Rad Labs Inc.、bioMérieux SA、Thermo Fisher Scientific Inc、Sight Diagnostics Ltd.、Gene POC、Ortho-Clinical Diagnostics、OJ-Bio Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：HIV POC、クロストリジウム・ディフィシルPOC、HBV POC、肺炎・連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TB・薬剤耐性結核POC ・用途別分析2016年-2026年：病院、クリニック、在宅、生活支援医療施設、研究所、その他 ・ポイントオブケア感染症の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ポイントオブケア感染症のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ポイントオブケア感染症のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ポイントオブケア感染症の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ポイントオブケア感染症の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Point of Care Infectious Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Point of Care Infectious Disease size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Point of Care Infectious Disease market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Point of Care Infectious Disease market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
Market segment by Application, can be divided into
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Market segment by players, this report covers
Siemens Healthineers
Trivitron Healthcare
F. Hoffmann-La Roche Ltd
Abbott
Quest Diagnostics, Inc
BD & Company
Chembio Diagnostics Inc
Trinity Biotech
Cardinal Health
Bio-Rad Labs Inc.
bioMérieux SA
Thermo Fisher Scientific Inc
Sight Diagnostics Ltd.
Gene POC
Ortho-Clinical Diagnostics
OJ-Bio Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Point of Care Infectious Disease
1.2 Classification of Point of Care Infectious Disease by Type
1.2.1 Overview: Global Point of Care Infectious Disease Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Point of Care Infectious Disease Revenue Market Share by Type in 2020
1.2.3 HIV POC
1.2.4 Clostridium difficile POC
1.2.5 HBV POC
1.2.6 Pneumonia or Streptococcus associated infections
1.2.7 Respiratory syncytial virus (RSV) POC
1.2.8 HPV POC
1.2.9 Influenza/Flu POC
1.2.10 HCV POC
1.2.11 MRSA POC
1.2.12 TB and drug-resistant TB POC
1.3 Global Point of Care Infectious Disease Market by Application
1.3.1 Overview: Global Point of Care Infectious Disease Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Global Point of Care Infectious Disease Market Size & Forecast
1.5 Global Point of Care Infectious Disease Market Size and Forecast by Region
1.5.1 Global Point of Care Infectious Disease Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Point of Care Infectious Disease Market Size by Region, (2016-2021)
1.5.3 North America Point of Care Infectious Disease Market Size and Prospect (2016-2026)
1.5.4 Europe Point of Care Infectious Disease Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Point of Care Infectious Disease Market Size and Prospect (2016-2026)
1.5.6 South America Point of Care Infectious Disease Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Point of Care Infectious Disease Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Point of Care Infectious Disease Market Drivers
1.6.2 Point of Care Infectious Disease Market Restraints
1.6.3 Point of Care Infectious Disease Trends Analysis
2 Company Profiles
2.1 Siemens Healthineers
2.1.1 Siemens Healthineers Details
2.1.2 Siemens Healthineers Major Business
2.1.3 Siemens Healthineers Point of Care Infectious Disease Product and Solutions
2.1.4 Siemens Healthineers Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Siemens Healthineers Recent Developments and Future Plans
2.2 Trivitron Healthcare
2.2.1 Trivitron Healthcare Details
2.2.2 Trivitron Healthcare Major Business
2.2.3 Trivitron Healthcare Point of Care Infectious Disease Product and Solutions
2.2.4 Trivitron Healthcare Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Trivitron Healthcare Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche Ltd
2.3.1 F. Hoffmann-La Roche Ltd Details
2.3.2 F. Hoffmann-La Roche Ltd Major Business
2.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Product and Solutions
2.3.4 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Point of Care Infectious Disease Product and Solutions
2.4.4 Abbott Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Abbott Recent Developments and Future Plans
2.5 Quest Diagnostics, Inc
2.5.1 Quest Diagnostics, Inc Details
2.5.2 Quest Diagnostics, Inc Major Business
2.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Product and Solutions
2.5.4 Quest Diagnostics, Inc Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Quest Diagnostics, Inc Recent Developments and Future Plans
2.6 BD & Company
2.6.1 BD & Company Details
2.6.2 BD & Company Major Business
2.6.3 BD & Company Point of Care Infectious Disease Product and Solutions
2.6.4 BD & Company Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 BD & Company Recent Developments and Future Plans
2.7 Chembio Diagnostics Inc
2.7.1 Chembio Diagnostics Inc Details
2.7.2 Chembio Diagnostics Inc Major Business
2.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Product and Solutions
2.7.4 Chembio Diagnostics Inc Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Chembio Diagnostics Inc Recent Developments and Future Plans
2.8 Trinity Biotech
2.8.1 Trinity Biotech Details
2.8.2 Trinity Biotech Major Business
2.8.3 Trinity Biotech Point of Care Infectious Disease Product and Solutions
2.8.4 Trinity Biotech Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Trinity Biotech Recent Developments and Future Plans
2.9 Cardinal Health
2.9.1 Cardinal Health Details
2.9.2 Cardinal Health Major Business
2.9.3 Cardinal Health Point of Care Infectious Disease Product and Solutions
2.9.4 Cardinal Health Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Cardinal Health Recent Developments and Future Plans
2.10 Bio-Rad Labs Inc.
2.10.1 Bio-Rad Labs Inc. Details
2.10.2 Bio-Rad Labs Inc. Major Business
2.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Product and Solutions
2.10.4 Bio-Rad Labs Inc. Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Bio-Rad Labs Inc. Recent Developments and Future Plans
2.11 bioMérieux SA
2.11.1 bioMérieux SA Details
2.11.2 bioMérieux SA Major Business
2.11.3 bioMérieux SA Point of Care Infectious Disease Product and Solutions
2.11.4 bioMérieux SA Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 bioMérieux SA Recent Developments and Future Plans
2.12 Thermo Fisher Scientific Inc
2.12.1 Thermo Fisher Scientific Inc Details
2.12.2 Thermo Fisher Scientific Inc Major Business
2.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Product and Solutions
2.12.4 Thermo Fisher Scientific Inc Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
2.13 Sight Diagnostics Ltd.
2.13.1 Sight Diagnostics Ltd. Details
2.13.2 Sight Diagnostics Ltd. Major Business
2.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Product and Solutions
2.13.4 Sight Diagnostics Ltd. Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Sight Diagnostics Ltd. Recent Developments and Future Plans
2.14 Gene POC
2.14.1 Gene POC Details
2.14.2 Gene POC Major Business
2.14.3 Gene POC Point of Care Infectious Disease Product and Solutions
2.14.4 Gene POC Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Gene POC Recent Developments and Future Plans
2.15 Ortho-Clinical Diagnostics
2.15.1 Ortho-Clinical Diagnostics Details
2.15.2 Ortho-Clinical Diagnostics Major Business
2.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Product and Solutions
2.15.4 Ortho-Clinical Diagnostics Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Ortho-Clinical Diagnostics Recent Developments and Future Plans
2.16 OJ-Bio Ltd.
2.16.1 OJ-Bio Ltd. Details
2.16.2 OJ-Bio Ltd. Major Business
2.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Product and Solutions
2.16.4 OJ-Bio Ltd. Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 OJ-Bio Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Point of Care Infectious Disease Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Point of Care Infectious Disease Players Market Share
3.2.2 Top 10 Point of Care Infectious Disease Players Market Share
3.2.3 Market Competition Trend
3.3 Point of Care Infectious Disease Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Point of Care Infectious Disease Revenue and Market Share by Type (2016-2021)
4.2 Global Point of Care Infectious Disease Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Point of Care Infectious Disease Revenue Market Share by Application (2016-2021)
5.2 Point of Care Infectious Disease Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Point of Care Infectious Disease Revenue by Type (2016-2026)
6.2 North America Point of Care Infectious Disease Revenue by Application (2016-2026)
6.3 North America Point of Care Infectious Disease Market Size by Country
6.3.1 North America Point of Care Infectious Disease Revenue by Country (2016-2026)
6.3.2 United States Point of Care Infectious Disease Market Size and Forecast (2016-2026)
6.3.3 Canada Point of Care Infectious Disease Market Size and Forecast (2016-2026)
6.3.4 Mexico Point of Care Infectious Disease Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Point of Care Infectious Disease Revenue by Type (2016-2026)
7.2 Europe Point of Care Infectious Disease Revenue by Application (2016-2026)
7.3 Europe Point of Care Infectious Disease Market Size by Country
7.3.1 Europe Point of Care Infectious Disease Revenue by Country (2016-2026)
7.3.2 Germany Point of Care Infectious Disease Market Size and Forecast (2016-2026)
7.3.3 France Point of Care Infectious Disease Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Point of Care Infectious Disease Market Size and Forecast (2016-2026)
7.3.5 Russia Point of Care Infectious Disease Market Size and Forecast (2016-2026)
7.3.6 Italy Point of Care Infectious Disease Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Point of Care Infectious Disease Revenue by Type (2016-2026)
8.2 Asia-Pacific Point of Care Infectious Disease Revenue by Application (2016-2026)
8.3 Asia-Pacific Point of Care Infectious Disease Market Size by Region
8.3.1 Asia-Pacific Point of Care Infectious Disease Revenue by Region (2016-2026)
8.3.2 China Point of Care Infectious Disease Market Size and Forecast (2016-2026)
8.3.3 Japan Point of Care Infectious Disease Market Size and Forecast (2016-2026)
8.3.4 South Korea Point of Care Infectious Disease Market Size and Forecast (2016-2026)
8.3.5 India Point of Care Infectious Disease Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Point of Care Infectious Disease Market Size and Forecast (2016-2026)
8.3.7 Australia Point of Care Infectious Disease Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Point of Care Infectious Disease Revenue by Type (2016-2026)
9.2 South America Point of Care Infectious Disease Revenue by Application (2016-2026)
9.3 South America Point of Care Infectious Disease Market Size by Country
9.3.1 South America Point of Care Infectious Disease Revenue by Country (2016-2026)
9.3.2 Brazil Point of Care Infectious Disease Market Size and Forecast (2016-2026)
9.3.3 Argentina Point of Care Infectious Disease Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Point of Care Infectious Disease Revenue by Type (2016-2026)
10.2 Middle East & Africa Point of Care Infectious Disease Revenue by Application (2016-2026)
10.3 Middle East & Africa Point of Care Infectious Disease Market Size by Country
10.3.1 Middle East & Africa Point of Care Infectious Disease Revenue by Country (2016-2026)
10.3.2 Turkey Point of Care Infectious Disease Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Point of Care Infectious Disease Market Size and Forecast (2016-2026)
10.3.4 UAE Point of Care Infectious Disease Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Point of Care Infectious Disease Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Point of Care Infectious Disease Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Point of Care Infectious Disease Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Point of Care Infectious Disease Revenue (USD Million) by Region (2016-2021)
Table 5. Global Point of Care Infectious Disease Revenue Market Share by Region (2021-2026)
Table 6. Siemens Healthineers Corporate Information, Head Office, and Major Competitors
Table 7. Siemens Healthineers Major Business
Table 8. Siemens Healthineers Point of Care Infectious Disease Product and Solutions
Table 9. Siemens Healthineers Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Trivitron Healthcare Corporate Information, Head Office, and Major Competitors
Table 11. Trivitron Healthcare Major Business
Table 12. Trivitron Healthcare Point of Care Infectious Disease Product and Solutions
Table 13. Trivitron Healthcare Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. F. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors
Table 15. F. Hoffmann-La Roche Ltd Major Business
Table 16. F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Product and Solutions
Table 17. F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Abbott Corporate Information, Head Office, and Major Competitors
Table 19. Abbott Major Business
Table 20. Abbott Point of Care Infectious Disease Product and Solutions
Table 21. Abbott Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Quest Diagnostics, Inc Corporate Information, Head Office, and Major Competitors
Table 23. Quest Diagnostics, Inc Major Business
Table 24. Quest Diagnostics, Inc Point of Care Infectious Disease Product and Solutions
Table 25. Quest Diagnostics, Inc Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. BD & Company Corporate Information, Head Office, and Major Competitors
Table 27. BD & Company Major Business
Table 28. BD & Company Point of Care Infectious Disease Product and Solutions
Table 29. BD & Company Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Chembio Diagnostics Inc Corporate Information, Head Office, and Major Competitors
Table 31. Chembio Diagnostics Inc Major Business
Table 32. Chembio Diagnostics Inc Point of Care Infectious Disease Product and Solutions
Table 33. Chembio Diagnostics Inc Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Trinity Biotech Corporate Information, Head Office, and Major Competitors
Table 35. Trinity Biotech Major Business
Table 36. Trinity Biotech Point of Care Infectious Disease Product and Solutions
Table 37. Trinity Biotech Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Cardinal Health Corporate Information, Head Office, and Major Competitors
Table 39. Cardinal Health Major Business
Table 40. Cardinal Health Point of Care Infectious Disease Product and Solutions
Table 41. Cardinal Health Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Bio-Rad Labs Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Bio-Rad Labs Inc. Major Business
Table 44. Bio-Rad Labs Inc. Point of Care Infectious Disease Product and Solutions
Table 45. Bio-Rad Labs Inc. Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. bioMérieux SA Corporate Information, Head Office, and Major Competitors
Table 47. bioMérieux SA Major Business
Table 48. bioMérieux SA Point of Care Infectious Disease Product and Solutions
Table 49. bioMérieux SA Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Thermo Fisher Scientific Inc Corporate Information, Head Office, and Major Competitors
Table 51. Thermo Fisher Scientific Inc Major Business
Table 52. Thermo Fisher Scientific Inc Point of Care Infectious Disease Product and Solutions
Table 53. Thermo Fisher Scientific Inc Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Sight Diagnostics Ltd. Corporate Information, Head Office, and Major Competitors
Table 55. Sight Diagnostics Ltd. Major Business
Table 56. Sight Diagnostics Ltd. Point of Care Infectious Disease Product and Solutions
Table 57. Sight Diagnostics Ltd. Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Gene POC Corporate Information, Head Office, and Major Competitors
Table 59. Gene POC Major Business
Table 60. Gene POC Point of Care Infectious Disease Product and Solutions
Table 61. Gene POC Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Ortho-Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 63. Ortho-Clinical Diagnostics Major Business
Table 64. Ortho-Clinical Diagnostics Point of Care Infectious Disease Product and Solutions
Table 65. Ortho-Clinical Diagnostics Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. OJ-Bio Ltd. Corporate Information, Head Office, and Major Competitors
Table 67. OJ-Bio Ltd. Major Business
Table 68. OJ-Bio Ltd. Point of Care Infectious Disease Product and Solutions
Table 69. OJ-Bio Ltd. Point of Care Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Point of Care Infectious Disease Revenue (USD Million) by Players (2019-2021)
Table 71. Global Point of Care Infectious Disease Revenue Share by Players (2019-2021)
Table 72. Breakdown of Point of Care Infectious Disease by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Point of Care Infectious Disease Players Head Office, Products and Services Provided
Table 74. Point of Care Infectious Disease Mergers & Acquisitions in the Past Five Years
Table 75. Point of Care Infectious Disease New Entrants and Expansion Plans
Table 76. Global Point of Care Infectious Disease Revenue (USD Million) by Type (2016-2021)
Table 77. Global Point of Care Infectious Disease Revenue Share by Type (2016-2021)
Table 78. Global Point of Care Infectious Disease Revenue Forecast by Type (2021-2026)
Table 79. Global Point of Care Infectious Disease Revenue by Application (2016-2021)
Table 80. Global Point of Care Infectious Disease Revenue Forecast by Application (2021-2026)
Table 81. North America Point of Care Infectious Disease Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Point of Care Infectious Disease Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Point of Care Infectious Disease Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Point of Care Infectious Disease Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Point of Care Infectious Disease Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Point of Care Infectious Disease Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Point of Care Infectious Disease Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Point of Care Infectious Disease Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Point of Care Infectious Disease Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Point of Care Infectious Disease Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Point of Care Infectious Disease Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Point of Care Infectious Disease Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Point of Care Infectious Disease Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Point of Care Infectious Disease Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Point of Care Infectious Disease Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Point of Care Infectious Disease Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Point of Care Infectious Disease Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Point of Care Infectious Disease Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Point of Care Infectious Disease Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Point of Care Infectious Disease Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Point of Care Infectious Disease Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Point of Care Infectious Disease Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Point of Care Infectious Disease Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Point of Care Infectious Disease Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Point of Care Infectious Disease Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Point of Care Infectious Disease Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Point of Care Infectious Disease Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Point of Care Infectious Disease Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Point of Care Infectious Disease Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Point of Care Infectious Disease Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Point of Care Infectious Disease Picture
Figure 2. Global Point of Care Infectious Disease Revenue Market Share by Type in 2020
Figure 3. HIV POC
Figure 4. Clostridium difficile POC
Figure 5. HBV POC
Figure 6. Pneumonia or Streptococcus associated infections
Figure 7. Respiratory syncytial virus (RSV) POC
Figure 8. HPV POC
Figure 9. Influenza/Flu POC
Figure 10. HCV POC
Figure 11. MRSA POC
Figure 12. TB and drug-resistant TB POC
Figure 13. Point of Care Infectious Disease Revenue Market Share by Application in 2020
Figure 14. Hospitals Picture
Figure 15. Clinics Picture
Figure 16. Home Picture
Figure 17. Assisted Living Healthcare Facilities Picture
Figure 18. Laboratories Picture
Figure 19. Others Picture
Figure 20. Global Point of Care Infectious Disease Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 21. Global Point of Care Infectious Disease Revenue and Forecast (2016-2026) & (USD Million)
Figure 22. Global Point of Care Infectious Disease Revenue Market Share by Region (2016-2026)
Figure 23. Global Point of Care Infectious Disease Revenue Market Share by Region in 2020
Figure 24. North America Point of Care Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Europe Point of Care Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 26. Asia-Pacific Point of Care Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 27. South America Point of Care Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 28. Middle East and Africa Point of Care Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 29. Point of Care Infectious Disease Market Drivers
Figure 30. Point of Care Infectious Disease Market Restraints
Figure 31. Point of Care Infectious Disease Market Trends
Figure 32. Siemens Healthineers Recent Developments and Future Plans
Figure 33. Trivitron Healthcare Recent Developments and Future Plans
Figure 34. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Figure 35. Abbott Recent Developments and Future Plans
Figure 36. Quest Diagnostics, Inc Recent Developments and Future Plans
Figure 37. BD & Company Recent Developments and Future Plans
Figure 38. Chembio Diagnostics Inc Recent Developments and Future Plans
Figure 39. Trinity Biotech Recent Developments and Future Plans
Figure 40. Cardinal Health Recent Developments and Future Plans
Figure 41. Bio-Rad Labs Inc. Recent Developments and Future Plans
Figure 42. bioMérieux SA Recent Developments and Future Plans
Figure 43. Thermo Fisher Scientific Inc Recent Developments and Future Plans
Figure 44. Sight Diagnostics Ltd. Recent Developments and Future Plans
Figure 45. Gene POC Recent Developments and Future Plans
Figure 46. Ortho-Clinical Diagnostics Recent Developments and Future Plans
Figure 47. OJ-Bio Ltd. Recent Developments and Future Plans
Figure 48. Global Point of Care Infectious Disease Revenue Share by Players in 2020
Figure 49. Point of Care Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 50. Global Top 3 Players Point of Care Infectious Disease Revenue Market Share in 2020
Figure 51. Global Top 10 Players Point of Care Infectious Disease Revenue Market Share in 2020
Figure 52. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 53. Global Point of Care Infectious Disease Revenue Share by Type in 2020
Figure 54. Global Point of Care Infectious Disease Market Share Forecast by Type (2021-2026)
Figure 55. Global Point of Care Infectious Disease Revenue Share by Application in 2020
Figure 56. Global Point of Care Infectious Disease Market Share Forecast by Application (2021-2026)
Figure 57. North America Point of Care Infectious Disease Sales Market Share by Type (2016-2026)
Figure 58. North America Point of Care Infectious Disease Sales Market Share by Application (2016-2026)
Figure 59. North America Point of Care Infectious Disease Revenue Market Share by Country (2016-2026)
Figure 60. United States Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Canada Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Mexico Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Europe Point of Care Infectious Disease Sales Market Share by Type (2016-2026)
Figure 64. Europe Point of Care Infectious Disease Sales Market Share by Application (2016-2026)
Figure 65. Europe Point of Care Infectious Disease Revenue Market Share by Country (2016-2026)
Figure 66. Germany Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. France Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. United Kingdom Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Russia Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Italy Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Asia-Pacific Point of Care Infectious Disease Sales Market Share by Type (2016-2026)
Figure 72. Asia-Pacific Point of Care Infectious Disease Sales Market Share by Application (2016-2026)
Figure 73. Asia-Pacific Point of Care Infectious Disease Revenue Market Share by Region (2016-2026)
Figure 74. China Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Japan Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Korea Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. India Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Southeast Asia Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Australia Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South America Point of Care Infectious Disease Sales Market Share by Type (2016-2026)
Figure 81. South America Point of Care Infectious Disease Sales Market Share by Application (2016-2026)
Figure 82. South America Point of Care Infectious Disease Revenue Market Share by Country (2016-2026)
Figure 83. Brazil Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Argentina Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Middle East and Africa Point of Care Infectious Disease Sales Market Share by Type (2016-2026)
Figure 86. Middle East and Africa Point of Care Infectious Disease Sales Market Share by Application (2016-2026)
Figure 87. Middle East and Africa Point of Care Infectious Disease Revenue Market Share by Country (2016-2026)
Figure 88. Turkey Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. Saudi Arabia Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 90. UAE Point of Care Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 91. Methodology
Figure 92. Research Process and Data Source
世界の感染症ポイントオブケア診断市場 2021：企業別、地域別、種類・用途別 The Infectious Disease Point of Care Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 世界のB型肝炎感染症検査市場 2021：企業別、地域別、種類・用途別 The Hepatitis B Infectious Disease Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- IVD感染症市場：世界及び中国市場分析・予測（～2024年） IVD Infectious Disease Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global IVD Infectious Disease industry with a focus on the Chinese market. The report provides key statistics on the market status of the IVD Infectious Disease m…
- 獣医感染症診断の世界市場 2019年版：種類別（免疫診断、分子診断、その他の技術）、用途別（ラボ、病院、クリニック、その他） Scope of the Report: The global Veterinary Infectious Disease Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, espe…
- ポイントオブケア（POC）分子診断の世界市場… Scope of the Report: The global Point-of-Care Molecular Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…